01.24.20

Optimal Atropine Concentration for Two Year Myopia Control Affirmed

Source: Reuters

Atropine 0.05% remains the optimal concentration for slowing myopia progression among Chinese children, the LAMP study extension shows, according to a Reuters report.

In a 2011 study, atropine 0.01% – but not 0.1% or 0.5% – resulted in better myopia control in the second year of treatment than in the first year (http://bit.ly/374fGK5), Dr. Jason Yam of the Chinese University of Hong Kong told Reuters Health by email. “This led to the suggestion of similar efficacy of 0.01% atropine with 0.5% and 0.1% atropine over two years.”

By contrast, the first-year results of the LAMP (Low-concentration Atropine for Myopia Progression) study showed that 0.05% atropine conferred the best treatment-side effect ratio among 0.05%, 0.025%, and 0.01%.

Read the full article.

Related Content